Why Your Biotech Patent Keeps Getting Rejected, and What to Do About It. If your biotech patent application keeps getting rejected, it’s tempting to blame the patent examiner. But in most cases, the real issue is a weak patenting strategy or poor execution  — both of which can be fixed. Here’s how to diagnose what’s going wrong and turn things around. Point 1 – Are You Relying on Only One Examiner and One Claiming Strategy? If you have only one application, one examiner, and one claiming...

INTRODUCTORY COMMENTS RE: BIOTECH/PHARMA EXTENDED PATENT FAMILIES In complex art areas like biotech/biopharma, patent strategy is about building extended patent families in key jurisdictions throughout the world, and especially in the U.S. This buildout should include numerous issued patents of different claim types and scope, from numerous related patent filings. These related filings typically share a lot of common disclosure, with numerous subsequent filings, typically provisional patent...

A day to celebrate biotech! 🥳 Congrats to Vertex and CRISPR Therapeutics on FDA approval of CASGEVY • 1st product that uses gene editing (See Exa-cel below for more info) And Bluebird for FDA approval yesterday of Lyfgenia • another autologous stem cell-based gene therapy to treat Sickle cell disease Interesting that both were approved on a single-arm (no control arm) trial, as the FDA is more willing to accept this data for a rare genetic disease with a high unmet need, and a strong...